News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
224 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17922)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (154)
2 (6)
3 (12)
4 (274)
5 (260)
6 (237)
7 (220)
8 (212)
9 (3)
10 (10)
11 (235)
12 (224)
13 (213)
14 (181)
15 (49)
16 (1)
18 (153)
19 (254)
20 (233)
21 (215)
22 (111)
23 (5)
24 (5)
25 (226)
26 (269)
27 (322)
28 (307)
29 (150)
30 (4)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Opportunity – Market Forecast (2020-2030)
The isothermal nucleic acid amplification technology/INAAT market has been estimated to experience numerous growth opportunities in the following years.
April 12, 2022
·
5 min read
Endovenous Laser Therapy Market: Rising incidence of varicose veins to drive the market
Endovenous laser therapy has been used for the treatment of varicose veins with significant success, especially in adult populations with saphenous insufficiency.
April 12, 2022
·
6 min read
Sexually Transmitted Diseases (STD) Testing Market Growth Opportunities and Upcoming Trends in the Industry – Forecast [2022-2030]
The sexually transmitted diseases testing market has been projected to grow at a noticeable speed in the foreseeable years.
April 12, 2022
·
5 min read
Retinal Biologics Market is Anticipated to Reach a Value of US$ 41.92 Billion by 2028 - Comprehensive Research Report By FMI
Retinal Biologics Market value surpassed US$ 19.96 Bn in 2022 and projected to grow at 10.7% y-o-y in 2019, as per a new Future Market Insights study.
April 12, 2022
·
6 min read
Business
Sequana Medical announces 2021 Full Year Results and 2022 Outlook
Sequana Medical NV announces its financial results for the year ended 31 December 2021, and provides a business update and an outlook for the remainder of 2022.
April 12, 2022
·
23 min read
Captor Therapeutics announces molecular targets of CT-01 program developing TPD therapy for hepatocellular carcinoma
Captor Therapeutics S.A. announces the molecular targets of one of its core pipeline projects designated CT-01, which is focused on the development of TPD therapy for hepatocellular carcinoma.
April 12, 2022
·
3 min read
Sensorion to Attend the Kempen Life Sciences, Cell & Gene Meeting on the Mediterranean Conferences in April 2022
Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that CEO Nawal Ouzren will attend in person two investor meetings in April 2022.
April 12, 2022
·
3 min read
Genetown
PureTech Announces Publication of Research from Collaborators Demonstrating PureTech’s Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy)
PureTech Health plc announced the publication of preclinical proof-of-concept demonstrating that PureTech’s Glyph platform can enhance the oral bioavailability of buprenorphine, a clinically-validated opioid replacement therapy, further expanding the range of clinically-validated drug classes shown to be amenable to the Glyph technology.
April 12, 2022
·
8 min read
Job Trends
Engitix Announces Expanded Collaboration and Licensing Agreement with Takeda to Develop New Anti-Fibrotic Therapies in Inflammatory Bowel Disease
Engitix Ltd, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix platform, entered into an agreement with Takeda to expand an existing collaboration to now include the discovery and development of novel therapeutics for fibrostenotic inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.
April 12, 2022
·
5 min read
BioForest
Aurion Biotech Raises $120 Million from Deerfield Management, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures
Deerfield Partner Andrew ElBardissi, M.D. and Petrichor Partner Patrick Lally to Join Aurion Biotech Board Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, announced it has secured a $120 million financing with top-tier biotech and ophthalmology investors.
April 12, 2022
·
5 min read
Previous
21 of 23
Next